170 related articles for article (PubMed ID: 7531661)
1. [Leukocyte and lymphocyte populations in peripheral blood and malignant ascites in patients with ovarian carcinoma].
Radke J; Schmidt D; Böhme M; Morenz J; Weise W
Geburtshilfe Frauenheilkd; 1994 Dec; 54(12):675-8. PubMed ID: 7531661
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic and functional analysis of tumor-infiltrating lymphocytes compared with tumor-associated lymphocytes from ascitic fluid and peripheral blood lymphocytes in patients with advanced ovarian cancer.
Santin AD; Hermonat PL; Ravaggi A; Bellone S; Roman JJ; Smith CV; Pecorelli S; Radominska-Pandya A; Cannon MJ; Parham GP
Gynecol Obstet Invest; 2001; 51(4):254-61. PubMed ID: 11408737
[TBL] [Abstract][Full Text] [Related]
3. Distinctive increases in HLA-DR+ and CD8+57+ lymphocyte subsets in Wegener's granulomatosis.
Ikeda M; Watanabe Y; Kitahara S; Inouye T
Int Arch Allergy Immunol; 1993; 102(2):205-8. PubMed ID: 7691301
[TBL] [Abstract][Full Text] [Related]
4. [Lymphocyte activation markers in patients with ovarian cancer].
Nowicka A; Rogala E; Bednarek W; Barczyński B; Wertel I; Piekarczyk W; Kotarski J
Ginekol Pol; 2012 Oct; 83(10):737-43. PubMed ID: 23383558
[TBL] [Abstract][Full Text] [Related]
5. CD69+ and HLA-DR+ activation antigens on peripheral blood lymphocyte populations in metastatic breast and ovarian cancer patients: correlations with survival following active specific immunotherapy.
Yacyshyn MB; Poppema S; Berg A; MacLean GD; Reddish MA; Meikle A; Longenecker BM
Int J Cancer; 1995 May; 61(4):470-4. PubMed ID: 7538976
[TBL] [Abstract][Full Text] [Related]
6. Changes of lymphocyte subsets in peripheral blood before and after operation of patients with advanced ovarian carcinoma.
Kikuchi Y; Iwano I; Kita T; Miyauchi M; Kuki E; Oomori K; Nagata I
J Cancer Res Clin Oncol; 1990; 116(3):283-7. PubMed ID: 2142487
[TBL] [Abstract][Full Text] [Related]
7. Peripheral blood lymphocyte subsets in urinary bladder carcinoma patients.
Gaafar T; Lotfy M; el Ridi R
Arch Immunol Ther Exp (Warsz); 1991; 39(5-6):511-7. PubMed ID: 1726772
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic characterization of infiltrating leukocytes in benign prostatic hyperplasia.
Theyer G; Kramer G; Assmann I; Sherwood E; Preinfalk W; Marberger M; Zechner O; Steiner GE
Lab Invest; 1992 Jan; 66(1):96-107. PubMed ID: 1370561
[TBL] [Abstract][Full Text] [Related]
9. CD57+ T lymphocytes are derived from CD57- precursors by differentiation occurring in late immune responses.
d'Angeac AD; Monier S; Pilling D; Travaglio-Encinoza A; Rème T; Salmon M
Eur J Immunol; 1994 Jul; 24(7):1503-11. PubMed ID: 7517872
[TBL] [Abstract][Full Text] [Related]
10. Triple immunofluorescence flow cytometry, using whole blood, of CD4+ and CD8+ lymphocytes expressing CD45RO and CD45RA.
Gruber R; Reiter C; Riethmüller G
J Immunol Methods; 1993 Aug; 163(2):173-9. PubMed ID: 8102628
[TBL] [Abstract][Full Text] [Related]
11. Tumor cytolysis by lymphocytes infiltrating ovarian malignant ascites.
Ioannides CG; Platsoucas CD; Rashed S; Wharton JT; Edwards CL; Freedman RS
Cancer Res; 1991 Aug; 51(16):4257-65. PubMed ID: 1868446
[TBL] [Abstract][Full Text] [Related]
12. Changes in populations of HLA-DR+CD3+ cells and CD57-CD16+ cells in alopecia areata after corticosteroid therapy.
Imai R; Takamori K; Ogawa H
Dermatology; 1994; 188(2):103-7. PubMed ID: 7511010
[TBL] [Abstract][Full Text] [Related]
13. Expression of activation antigens on lymphocyte surface and circulating platelet-leukocyte aggregates in ischaemic heart disease.
Czyz A; Kołacz E; Angerer D; Zawilska K
Kardiol Pol; 2005 Mar; 62(3):189-200; discussion 201. PubMed ID: 15830013
[TBL] [Abstract][Full Text] [Related]
14. Lymphocyte subsets and specific T-cell immune response in thalassemia.
Pattanapanyasat K; Thepthai C; Lamchiagdhase P; Lerdwana S; Tachavanich K; Thanomsuk P; Wanachiwanawin W; Fucharoen S; Darden JM
Cytometry; 2000 Feb; 42(1):11-7. PubMed ID: 10679738
[TBL] [Abstract][Full Text] [Related]
15. [Lymphocyte subpopulations in the surface secretion on the adenoid].
Debkowska I; Hassmann-Poznańska E; Wysocka J; Kasprzycka E; Ratomski K
Otolaryngol Pol; 2005; 59(1):63-9. PubMed ID: 15915921
[TBL] [Abstract][Full Text] [Related]
16. [Effect of granulocyte colony stimulating factor (G-CSF) on peripheral blood leukocytes and lymphocytes in patients with chemotherapy-induced leukopenia].
Böhme M; Schmidt D; Radke J; Morenz J; Weise W
Geburtshilfe Frauenheilkd; 1994 Dec; 54(12):670-4. PubMed ID: 7531660
[TBL] [Abstract][Full Text] [Related]
17. [Lymphocytic subpopulations in malignant ascites of ovarian origin. Flow cytometric analysis].
De Leonardis A; Casamassima A; Chiuri E; Addabbo L; De Frenza N; Falco G
Minerva Ginecol; 1993 Jun; 45(6):291-300. PubMed ID: 8355884
[TBL] [Abstract][Full Text] [Related]
18. The phenotype of ascitic fluid lymphocytes in patients with ovarian carcinoma and other primaries.
Melichar B; Tousková M; Tosner J; Kopecký O
Onkologie; 2001 Apr; 24(2):156-60. PubMed ID: 11441296
[TBL] [Abstract][Full Text] [Related]
19. [Lymphocytograms in relation to storage time of CPDA1 whole blood concentrates].
Menke-Möllers I; Burrichter H; Schiene K; Krüger J
Beitr Infusionsther; 1992; 30():140-4. PubMed ID: 1284691
[TBL] [Abstract][Full Text] [Related]
20. Defective clonogenic potential of CD8+ T lymphocytes in patients with AIDS. Expansion in vivo of a nonclonogenic CD3+CD8+DR+CD25- T cell population.
Pantaleo G; Koenig S; Baseler M; Lane HC; Fauci AS
J Immunol; 1990 Mar; 144(5):1696-704. PubMed ID: 2137842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
